Compumedics Limited
(ASX:CMP) has announced it has successfully completed a $6.5 million placement.
The placement is comprised of $4.5 million in new shares issued and a $2.0 million sell down of existing shares.
Shares were priced at $0.54, a 3 percent discount on the volume weighted average price immediately prior to the trading halt.
Compumedics Executive Chairman Dr David Burton has indicated the placement strengthens the company’s balance sheet and provides greater flexibility in pursuing commercialisation opportunities.
Compumedics Limited reported a net profit of $3.3 million at 30 June 2016.
